Trials / Unknown
UnknownNCT00089440
Assessment of Interactions Between Methamphetamine and Aripiprazole - 1
Assessment of Interactions Between IV Methamphetamine and Aripiprazole
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 17 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the interactions between intravenous methamphetamine and aripiprazole.
Detailed description
This is a double-blind, placebo-controlled human laboratory clinical pharmacology study to assess potential interactions between intravenous d-methamphetamine infusion and treatment with oral aripiprazole.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aripiprazole |
Timeline
- Start date
- 2004-06-01
- Completion
- 2005-03-01
- First posted
- 2004-08-06
- Last updated
- 2017-01-11
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00089440. Inclusion in this directory is not an endorsement.